SRTA is expected to report earnings to fall 191.67% to -2 cents per share on August 11
Q2'26
Est.
$-0.03
Q1'26
Beat
by $0.06
Q4'25
Missed
by $0.12
Q3'25
Missed
by $0.14
Q2'25
Est.
$-0.05
The last earnings report on May 06 showed earnings per share of 2 cents, beating the estimate of -2 cents. With 612.59K shares outstanding, the current market capitalization sits at 497.53M.
A.I. Advisor
published General Information
General Information
a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization
A.I.dvisor indicates that over the last year, SRTA has been loosely correlated with JOBY. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTA jumps, then JOBY could also see price increases.
SRTA sees its Stochastic Oscillator recovers from oversold territory
On June 16, 2026, the Stochastic Oscillator for SRTA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Technical Analysis (Indicators)
Bullish Trend Analysis
The 50-day moving average for SRTA moved above the 200-day moving average on May 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTA advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .
SRTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 186 cases where SRTA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for SRTA moved out of overbought territory on June 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRTA as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for SRTA turned negative on June 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.741) is normal, around the industry mean (224.384). P/E Ratio (0.000) is within average values for comparable stocks, (120.759). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.437). SRTA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.130) is also within normal values, averaging (2.531).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Strata Critical Medical (SRTA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
